GLENMARK PHARMA S
Bank of Baroda, Balrampur Chini Mills among 5 stocks with short covering
Short covering refers to the buying of shares in order to close an existing short position or a position that has been sold. Short covering signals a shift in view on security from extreme bearishness to bullishness. In Thursday's trading session, five stocks saw top short covering. Here's the list:
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
Expert panel to soon weigh plan to use generics for prescription drugs
An expert committee is set to discuss the feasibility of allowing generic substitutions for prescription drugs in India. The proposal has sparked a disagreement between the Indian Pharmaceutical Alliance (IPA) and the All India Drug Action Network (AIDAN). The IPA opposes the idea, arguing that it would lead to a surge of demand from trade channels, such as general pharmacy stores, which would not benefit patients.
Divi's Laboratories, Glenmark Pharma among 5 stocks with long unwinding
Long unwinding refers to the selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of impending bearishness. In Tuesday's trading session, five stocks witnessed a long unwinding. Here's the list:
Jubilant FoodWorks, Glenmark Pharma among 5 stocks with short covering
Short covering refers to the buying of shares in order to close an existing short position or a position that has been sold. Short covering signals a shift in view regarding a security from extreme bearishness to bullishness. In Monday's trading session, five stocks saw top short covering. Here's the list:
F&O stocks: SBI Life, Glenmark Pharma among 5 stocks with short buildup
SBI Life, Glenmark Pharma, and IOC were among the 5 stocks with a buildup of fresh short positions. Friday's trading session saw these stocks witnessing a rise in open interest as their prices declined.
- Go To Page 1
PFC, Glenmark Pharma among 5 stocks with short buildup
A short buildup is when there is a rise in open interest and volumes along with a decrease in the price of the underlying stock in the Futures and Options segment. Short buildup means more people are expecting the prices to go down and creating short positions. In Friday's trading session, five stocks witnessed a build of fresh short positions. Here's the list:
Ahead of June 4, be relatively light & in cash; curtail trading: Dipan Mehta
Dipan Mehta advises caution and light trading ahead of the upcoming election dates. He emphasizes the importance of being in cash and watching the election results closely for investment decisions.
Pharma an undervalued, under-owned, high on comfort space for next 1-2 years: N Jayakumar
I think the market is not necessarily differentiated between consumption in the rural or consumption in the urban space. I think in general, consumption stocks have been lacklustre, languid if you will, but I think large scale recoveries in the market have happened across the board.
Torrent Pharma, Glenmark Pharma shares jump up to 9% after Q4 results
Shares of Torrent Pharma and Glenmark Pharma surged post Q4 results. Torrent Pharma's net profit jumped 56% YoY while Glenmark Pharma reported increased losses. Motilal Oswal provides target prices for both companies.
Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. In FY24, Glenmark's consolidated revenue reached Rs. 11,813 crore, a 2% increase year-over-year. The company's EBITDA margin for the fiscal year was 10.1%, primarily due to a one-time impact on sales in the India business during the third quarter.
IndiGo, Adani Ports among 5 stocks with short buildup
A short buildup is when there is a rise in open interest and volumes along with a decrease in the price of the underlying stock in the Futures and Options segment. Short buildup means more people are expecting the prices to go down and creating short positions. In Friday's trading session, five stocks witnessed a build of fresh short positions. Here's the list:
Buy the dip in UPL; go long on Hindalco, says Vishal Malkan
Vishal Malkan analyzes the market's strong bottom at 22,000, recommends Tata Power, Sun Pharma, Glenmark stocks. Malkan further favours Ashok Leyland while suggesting UPL as a buy on dip. Metals showing strength, with Hindalco poised for gains. There is a very strong support for Hindalco at around 610-615 which was a resistance earlier. With that stop loss, one can go long for targets of 690 and 700 plus.
F&O stocks: Godrej Consumer Products, Cipla among 5 stocks with short buildup
In Tuesday's trading session, the following five stocks witnessed a build of fresh short positions. Let us first understand how this conclusion is reached that whether the stock has seen a buildup of fresh short position or not.
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug
Glenmark Pharmaceuticals received USFDA approval for generic Acetaminophen and Ibuprofen tablets. The product, a version of Advil Dual Action, will be distributed by Glenmark Therapeutics Inc, USA. Advil Dual Action achieved annual sales of around USD 84.1 million. Glenmark has 195 products authorized for distribution and 52 ANDAs pending approval.
5 small, midcap stocks where brokerages upgraded ratings this month
Q4 earnings season is in full swing and the brokerage firms are also actively monitoring the performance of the companies. Trendlyne has compiled data of small and midcap companies in which various brokerage firms have upgraded their ratings. Here’s the list:
National Aluminium, Dalmia Bharat among 5 stocks with short buildup
A short buildup is when there is a rise in open interest and volumes along with a decrease in the price of the underlying stock in the Futures and Options segment. Short buildup means more people are expecting the prices to go down and creating short positions. In Tuesday’s trading session, five stocks witnessed a build of fresh short positions. Here's the list:
Delhi HC upholds injunction against Glenmark Pharma
Sun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use drug names “Istamet” and “Indamet”, respectively, which Sun Pharma finds to be deceptively similar and confusing.
Pharma, healthcare top bets of fund managers in March
They also purchased insurance stocks like SBI Life, HDFC Life, and ICICI Prudential Life Insurance after favourable guidelines on the surrender value of policies were announced by the insurance regulator IRDAI. Also, the recent removal of the age limit on availing of health insurance is seen as boosting the prospects of life insurance companies.
NTPC, Glenmark Pharma among 5 stocks with long buildup
A long buildup occurs when there is an increase in open interest and trading volumes alongside a rise in the price of the underlying stock in the Futures and Options segment, indicating a bullish trend in the market. In Friday's trading session, five stocks experienced a buildup of fresh long positions. Here's the list:
Relief for pharma companies as API prices see a sharp fall
India's pharmaceutical industry, which is dependent on China for APIs, intermediates and bulk drugs, had seen an exponential price increase during Covid times. The rise in API prices continued until early this year. However, things have started to change, people in the know told ET.
Delhi High Court seeks response from govt, NPPA on Glenmark's plea
Delhi High Court hears Glenmark Pharma's petition against NPPA's pricing order for anti-diabetic drugs, claiming arbitrary pricing and seeking exemption due to DCGI approval.
Pharma stock set to rise 6%, realty player eyes 7% gain
Nifty saw a stronger-than-expected start to the session but gradually gave up its gains. It still closed with a modest gain.
PLI schemes attract over Rs 1.06 lakh crore investment till Dec; pharma sector gets major chunk
PLI schemes across sectors attracted significant investments by December 2023, notably in pharma and solar industries. While some sectors thrived, others like IT hardware, auto, and textiles faced tepid interest, prompting a review for scheme improvements.
Pharma raw material makers in race to tank up on CXO talent
Some of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded Sekhmet Pharmaventures, and Carlyle-backed Viyash Lifesciences and Sequent Scientific (animal API manufacturer).
Hot Stocks: 3 stocks which can give returns between 29-40%
ET looks at some of the latest stock recommendations by analysts. These stocks are expected to return between 29% and 40% as per analysts’ price targets.
F&O stocks: Trent, Glenmark Pharma among 5 stocks with short buildup
Coming to the buildup of fresh short positions, when the stock prices move downward and open interest on the counter increases, it is taken as a sign of a short build-up.
Reduce Glenmark Pharmaceuticals, target price Rs 780: ICICI Securities
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023.
Load More
